Surgery Partners (NASDAQ:SGRY) Sets New 12-Month Low - Should You Sell?

Surgery Partners, Inc. (NASDAQ:SGRY - Get Free Report)'s share price hit a new 52-week low during mid-day trading on Friday . The stock traded as low as $18.87 and last traded at $19.06, with a volume of 915827 shares changing hands. The stock had previously closed at $19.83.

Analyst Ratings Changes

SGRY has been the subject of several recent research reports. Benchmark reissued a "buy" rating and issued a $35.00 price target on shares of Surgery Partners in a research note on Monday, April 21st. Royal Bank Of Canada reiterated an "outperform" rating and issued a $35.00 target price on shares of Surgery Partners in a research note on Tuesday, March 25th. Barclays dropped their price target on shares of Surgery Partners from $25.00 to $24.00 and set an "equal weight" rating on the stock in a research note on Tuesday, May 27th. Finally, Macquarie cut their price target on shares of Surgery Partners from $34.00 to $33.00 and set an "outperform" rating on the stock in a report on Tuesday, March 11th. One analyst has rated the stock with a sell rating, three have issued a hold rating and seven have given a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $33.56.

Surgery Partners Stock Performance

The company has a debt-to-equity ratio of 1.09, a current ratio of 1.89 and a quick ratio of 1.73. The firm has a fifty day simple moving average of $22.36 and a 200 day simple moving average of $22.67. The company has a market cap of $2.59 billion, a price-to-earnings ratio of -13.20 and a beta of 1.93.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last posted its quarterly earnings data on Monday, May 12th. The company reported $0.04 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.08 by ($0.04). The firm had revenue of $776.00 million for the quarter, compared to the consensus estimate of $777.77 million. Surgery Partners had a positive return on equity of 2.41% and a negative net margin of 6.10%. Surgery Partners's quarterly revenue was up 8.2% on a year-over-year basis. During the same period in the prior year, the company posted $0.10 earnings per share. On average, sell-side analysts expect that Surgery Partners, Inc. will post 0.67 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Surgery Partners

Large investors have recently made changes to their positions in the business. Bayforest Capital Ltd bought a new position in Surgery Partners in the 1st quarter worth approximately $1,017,000. Woodline Partners LP acquired a new stake in shares of Surgery Partners in the first quarter worth $12,478,000. Empowered Funds LLC increased its position in Surgery Partners by 11.0% during the first quarter. Empowered Funds LLC now owns 12,853 shares of the company's stock worth $305,000 after acquiring an additional 1,278 shares during the period. Caxton Associates LLP acquired a new position in Surgery Partners during the 1st quarter valued at $4,351,000. Finally, Twin Securities Inc. acquired a new position in Surgery Partners during the 1st quarter valued at $7,844,000.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.